Bottom Line: Saama’s AI Tech Helps Pharma Bring Treatments to Patients Sooner
Because Saama embraces curiosity and ingenuity, our company attracts some of the brightest engineering and technology minds in the world today. Every single day, they apply their intellects to solving problems faced by biopharma and biotech companies to get life-enhancing and life-saving treatments, as well as vaccines, out into the world as quickly as possible.
When marketing engages in promoting a new artificial intelligence (AI) breakthrough or a new product capability that can actively detect drug safety signals, for example, it’s often described using complex technical terminology that requires decoding for our customers to understand how it helps them solve their day-to-day problems.
Fortunately, at Saama we have a culture that enables thought-leading technologists, data scientists, sales, and marketing to collaborate to ensure we get the right messages out to the right people.
The work is as exhilarating as it is challenging. As soon as we clearly articulate the value of a new capability, it’s highly likely there’s another capability being created, a customer finding a new application for our technology, or fresh groundbreaking research being discovered, creating the need to once again articulate clearly to the market the value to be gained.
Staying True to the Company Vision
Saama, like other innovative companies, is growing at a tremendous pace.
This dynamic environment poses several communications challenges for marketing, but we do a good job overcoming them by staying true to our company vision in everything we do.
Whether we’re communicating ideas related to human-in-the-loop AI, machine learning, active safety surveillance, predictive analytics, or natural language processing, we do it all for one reason: to help clinical researchers develop safe and effective treatments–and get them to patients–as quickly as possible.
While the details are constantly changing, our vision to reduce the time it takes to get new treatments to patients is unwavering. When professionals in clinical operations, medical review, data management, biostatistics, and pharmacovigilance understand that Saama can help them bring safe and effective treatments to patients faster than ever before, we’re doing our job well.
We all work in an industry with persistent threats around every corner, from cancer to COVID-19. Humanity depends on pharma to do everything it can to keep people healthy and improve their quality of life and everyone at Saama is proud to help accelerate this process across all therapeutic areas.
Websites need to continuously be improved and evolved with the latest tech and capabilities, especially at Software as a Service (SaaS) companies because customers interact with their software through a browser. As the first browser interaction a person has with a company, the main website is a direct reflection of what a customer can expect from the company’s software products. The fact that Saama’s website was recently recognized for excellence by the PM360 Pharma Choice Awards and Ragan’s PR Daily Awards are indications that we’re exceeding the industry’s expectations. We were up against some pretty impressive competition and it was truly an honor to be in such good company. So keep your eyes on the award-winning saama.com for more great things to come.
While I’m humbled by this recent recognition, working with such talented people creating Saama’s technology, and the marketers who so succinctly communicate the value to our customers, I’m even more honored to work with our customers who leverage Saama technology to deliver hope to patients sooner, like getting the first COVID-19 vaccine out a month earlier than believed possible. Bravo to science and tech. Let’s keep up the great work.